Abstract
Atherosclerosis is a multifactorial disease that is caused by many years of exposure to atherogenic stimuli that already at a young age lead to early lesions, the so-called "fatty streaks". One of the mechanisms involved in atherogenesis is the activated blood coagulation system, but its primary role in this process has not been established. From the fatty streak onwards, evidence of activated coagulation is histologically present in the form of fibrin/fibrinogen molecules. With advancing lesions, the presence of tissue factor protein, introduced by invading macrophages or locally expressed by vascular smooth muscle cells (VSMC) becomes more prominent. Tissue factor has been shown to be an important agonist of arterial thrombosis upon erosion of the luminal plaque surface or frank rupture of plaques. Recent data indicate the production of factor VII, probably expressed by VSMC in plaque lesions, which raises the possibility that formation of a catalytic tissue factor/factor VIIa complex occurs in the atherosclerotic vessel wall. Theoretically, such a complex could then induce local generation of thrombin and fibrin molecules, but its precise role is still unknown. While fibrinogen/fibrin molecules participate in early plaque lesions, increased activity of systemic coagulation is of no major influence on the risk of arterial thrombosis, except in rare cases where a number of specific procoagulant forces collide. Despite the presence of tissue factor - factor VII complex it is unlikely that all fibrin in the atherosclerotic plaque is the direct result from local clotting activity. Evidence is accumulating that the tissue factor/factor VII complex is involved in important coagulation-independent biological processes (inflammation, cell migration, apoptosis), either via direct signal transduction through tissue factor or by (in)direct activation of protease activated receptors. The presence of localized vascular "mini-cascades" of coagulation proteins may target a new role of coagulation in vessel wall remodeling and plaque vulnerability.
Keywords: Coagulation, atherothrombosis, atherosclerosis, thrombin, fibrinogen
Current Genomics
Title: Blood Coagulation and the Risk of Atherothrombosis
Volume: 6 Issue: 6
Author(s): H. M.H. Spronk and H. T. Cate
Affiliation:
Keywords: Coagulation, atherothrombosis, atherosclerosis, thrombin, fibrinogen
Abstract: Atherosclerosis is a multifactorial disease that is caused by many years of exposure to atherogenic stimuli that already at a young age lead to early lesions, the so-called "fatty streaks". One of the mechanisms involved in atherogenesis is the activated blood coagulation system, but its primary role in this process has not been established. From the fatty streak onwards, evidence of activated coagulation is histologically present in the form of fibrin/fibrinogen molecules. With advancing lesions, the presence of tissue factor protein, introduced by invading macrophages or locally expressed by vascular smooth muscle cells (VSMC) becomes more prominent. Tissue factor has been shown to be an important agonist of arterial thrombosis upon erosion of the luminal plaque surface or frank rupture of plaques. Recent data indicate the production of factor VII, probably expressed by VSMC in plaque lesions, which raises the possibility that formation of a catalytic tissue factor/factor VIIa complex occurs in the atherosclerotic vessel wall. Theoretically, such a complex could then induce local generation of thrombin and fibrin molecules, but its precise role is still unknown. While fibrinogen/fibrin molecules participate in early plaque lesions, increased activity of systemic coagulation is of no major influence on the risk of arterial thrombosis, except in rare cases where a number of specific procoagulant forces collide. Despite the presence of tissue factor - factor VII complex it is unlikely that all fibrin in the atherosclerotic plaque is the direct result from local clotting activity. Evidence is accumulating that the tissue factor/factor VII complex is involved in important coagulation-independent biological processes (inflammation, cell migration, apoptosis), either via direct signal transduction through tissue factor or by (in)direct activation of protease activated receptors. The presence of localized vascular "mini-cascades" of coagulation proteins may target a new role of coagulation in vessel wall remodeling and plaque vulnerability.
Export Options
About this article
Cite this article as:
Spronk M.H. H. and Cate T. H., Blood Coagulation and the Risk of Atherothrombosis, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774483043
DOI https://dx.doi.org/10.2174/138920205774483043 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Management of Hypertension in the Acute Phase of Stroke
Current Hypertension Reviews Activation of the Innate Immune System in Atherosclerotic Disease
Current Pharmaceutical Design NPY Y1 and Y5 Receptor Selective Antagonists as Anti-Obesity Drugs
Current Topics in Medicinal Chemistry Postmenopausal Hormone Therapy
Current Women`s Health Reviews Healthy Diet and Reduction of Chronic Disease Risks of Night Shift Workers
Current Medicinal Chemistry A Practical Comprehensive Approach to Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
Current Pharmaceutical Design AMP-Activated Protein Kinase: Structure and Regulation
Current Protein & Peptide Science Role of Coronary Microvascular Endothelial Dysfunction in the Development of Heart Failure
Current Cardiology Reviews Antiplatelet Treatment in Ischemic Stroke Treatment
Current Topics in Medicinal Chemistry A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
Current Cardiology Reviews Virtual Screening Against Obesity
Current Medicinal Chemistry N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain
Current Pharmaceutical Design The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present)
Current Topics in Medicinal Chemistry Progression of Retinopathy in Type 1 Diabetic Women During Pregnancy
Current Diabetes Reviews Neurotrophins' Modulation by Olive Polyphenols
Current Medicinal Chemistry GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Relationship Between Proinsulin Level and Cardiovascular Risk Factors Clustering: An Epidemiological Study
Vascular Disease Prevention (Discontinued) Aspartic Proteinases in Disease: A Structural Perspective
Current Drug Targets